It is possible that aspects of the SOX2-driven “stem cell program” in normal and pathogenic (cancer) neural stem cells relies on similar target genes; on the other hand, some SOX2 targets may also differ in normal and tumorigenic stem cells, for example, via the presence of different SOX2 co-factors (see above, Section 4). The gene discussed is SOX2; the disease is cancer.